Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, December 23, 2015

Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin



Abstract

Conclusions:
Our finding that resistance to trabectedin is associated with the loss of NER function, with a consequent increased sensitivity to platinum drugs, provides the rational for sequential use of these drugs in patients who have acquired resistance to trabectedin.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.